[1]中国糖尿病足细胞与介入治疗技术联盟,中国医师协会介入医师分会介入医学与生物工程技术委员会,国家放射与治疗临床医学研究中心.糖尿病足介入综合诊治临床指南(第九版) [J].介入放射学杂志,2024,33(04):341-354.
 China Alliance of Cellular and Interventional Therapy Techniques for Diabetic Foot,Technical Committee on Interventional Medicine and Bioengineering of Chinese Intervention Physicians Branch,National Centre for Clinical Medical Research on Radiation and Treatment.Clinical guidelines for comprehensive interventional management of the diabetic foot(9th Edition) [J].journal interventional radiology,2024,33(04):341-354.
点击复制

糖尿病足介入综合诊治临床指南(第九版)

()

PDF下载中关闭

分享到:

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
33
期数:
2024年04
页码:
341-354
栏目:
指南与共识
出版日期:
2024-05-04

文章信息/Info

Title:
Clinical guidelines for comprehensive interventional management of the diabetic foot(9th Edition)
作者:
中国糖尿病足细胞与介入治疗技术联盟中国医师协会介入医师分会介入医学与生物工程技术委员会国家放射与治疗临床医学研究中心
Author(s):
China Alliance of Cellular and Interventional Therapy Techniques for Diabetic Foot Technical Committee on Interventional Medicine and Bioengineering of Chinese Intervention Physicians Branch National Centre for Clinical Medical Research on Radiation and Treatment
关键词:
【关键词】 糖尿病足 糖尿病 介入综合诊治 临床指南
文献标志码:
A
摘要:
【摘要】 糖尿病足作为糖尿病血管病常见并发症之一,具有高发病率、高致残率、高致死率和治愈率低的特点,严重影响糖尿病患者的身心健康和生活品质,却一直缺少统一的规范性治疗方法。中国糖尿病足细胞与介入治疗技术联盟曾于2015年制定了糖尿病足介入综合诊治临床指南(第一版),在一定程度上填补了国内糖尿病足规范性治疗的空白,对于提高我国糖尿病足治疗水平起到了支撑作用。近10年来,随着诊断标准和治疗方式的更新,以及国内外相关研究的不断深入,联盟组织国内89家单位在第八版的基础上进行新的修订,并颁布第九版指南,以期进一步规范我国糖尿病足临床诊治工作。本指南较第八版主要增加了糖尿病足下肢动脉狭窄或闭塞的腔内治疗原则,强调血管重建优先重建直线血流的原则,至少建立1支能够从股浅动脉起始端到达足部病变部位的直接供血动脉,对于膝下动脉多支病变治疗时建议遵循“先易后难”的重建原则,先处理容易开通的病变动脉,保证至少有1支血管能够供应到足部。同时本版指南介绍了同济大学“五点法皮温”设备在糖尿病足诊治中的巨大应用价值。

参考文献/References:

[1] Hingorani A, LaMuraglia GM, Henke P, et al. The management of diabetic foot: a clinical practice guideline by the Society for Vascular Surgery in collaboration with the American Podiatric Medical Association and the Society for Vascular Medicine[J]. J Vasc Surg, 2016, 63: 3S- 21S.
[2] 王爱红,薛 婧,许樟荣.糖尿病足临床治疗进展与展望[J]. 中华糖尿病杂志, 2022, 14:643- 649.
[3] 刘光辉,张其润,邱福轩. 血管腔内介入治疗糖尿病足的临床效果[J]. 临床医学研究与实践, 2022, 7:48- 50.
[4] Kalish J, Hamdan A. Management of diabetic foot problems[J]. J Vasc Surg, 2010, 51: 476- 486.
[5] 佟 雪. 对基于下肢血管超声诊断的糖尿病足溃疡患者治疗后临床效果及预后的研究[J]. 糖尿病新世界, 2022, 24:14- 17, 28.
[6] Li M. Guidelines and standards for comprehensive clinical diagnosis and interventional treatment for diabetic foot in China (Issue 7.0)[J]. J Interv Med,2021,4:117- 129.
[7] 中国糖尿病足细胞与介入治疗技术联盟,中国介入医师分会介入医学与生物工程技术委员会,国家放射与治疗临床医学研究中心. 糖尿病足介入综合诊治临床指南(第六版)[J]. 介入放射学杂志, 2020, 29:853- 866.
[8] 陈 隽,周一薇,李秀娟. 症状性下肢动脉疾病抗栓治疗分析[J]. 临床荟萃. 2021, 36: 937-941.
[9] 王 平,李棋蕊,许 闽. DSA联合微创介入治疗糖尿病足的疗效及护理对策[J]. 中国卫生标准管理, 2019, 10:115- 117.
[10] Barnes JA, Eid MA, Creager MA, et al. Epidemiology and risk of amputation in patients with diabetes mellitus and peripheral artery disease[J]. Arterioscler Thromb Vasc Biol, 2020, 40: 1808- 1817.
[11] Stoberock K,Kaschwich M,Nicolay SS,et al. The interrelationship between diabetes mellitus and peripheral arterial disease[J]. Vasa, 2021, 50: 323- 330.
[12] Ott C, Schmieder RE. Diagnosis and treatment of arterial hypertension 2021[J]. Kidney Int, 2022, 101: 36- 46.
[13] Aday AW, Matsushita K. Epidemiology of peripheral artery disease and polyvascular disease[J]. Circ Res, 2021, 128: 1818- 1832.
[14] Armstrong DG,Tan TW,Boulton AJM,et al. Diabetic foot ulcers: a review[J]. JAMA, 2023, 330: 62- 75.
[15] Lipsky BA, Senneville E, Abbas ZG, et al. Guidelines on the diagnosis and treatment of foot infection in persons with diabetes (IWGDF 2019 update)[J]. Diabetes Metab Res Rev, 2020, 36 Suppl 1: e3280.
[16] Zhang Z, Zhang W, Xu Y, et al. Efficacy of hyperbaric oxygen therapy for diabetic foot ulcers: an updated systematic review and meta- analysis[J]. Asian J Surg, 2022, 45: 68- 78.
[17] 《多学科合作下糖尿病足防治专家共识(2020版)》编写组. 多学科合作下糖尿病足防治专家共识(2020版)精华版(Ⅰ)[J]. 中华烧伤杂志, 2020, 36: 637- 646.
[18] Isaji T, Hosoi Y, Kogure K, et al. Drug- coated balloon versus plain balloon angioplasty in the treatment of infrainguinal vein bypass stenosis: a systematic review and meta- analysis[J]. J Clin Med, 2022, 12: 87.
[19] McDermott K,Fang M,Boulton AJM,et al. Etiology,epidemiology, and disparities in the burden of diabetic foot ulcers[J]. Diabetes Care, 2023, 46: 209- 221.
[20] Elraiyah T, Tsapas A, Prutsky G, et al. A systematic review and meta- analysis of adjunctive therapies in diabetic foot ulcers[J]. J Vasc Surg, 2016, 63: 46S- 58S.
[21] Meloni M, Izzo V, Vainieri E, et al. Management of negative pressure wound therapy in the treatment of diabetic foot ulcers[J]. World J Orthop, 2015, 6: 387- 393.
[22] Shi R, Jin Y, Cao C, et al. Localization of human adipose- derived stem cells and their effect in repair of diabetic foot ulcers in rats[J]. Stem Cell Res Ther, 2016, 7: 155.
[23] Xiu X, Zhang H, Xue A, et al. Genetic evidence for a causal relationship between type 2 diabetes and peripheral artery disease in both Europeans and East Asians[J]. BMC Med, 2022, 20: 300.
[24] Wang Y, Shao T, Wang J, et al. An update on potential biomarkers for diagnosing diabetic foot ulcer at early stage[J]. Biomed Pharmacother, 2021, 133: 110991.
[25] Chen L, Zhang S, Da J, et al. A systematic review and meta- analysis of efficacy and safety of negative pressure wound therapy in the treatment of diabetic foot ulcer[J]. Ann Palliat Med, 2021, 10: 10830- 10839.
[26] Catella J,Long A,Mazzolai L. What is currently the role of TcPO2 in the choice of the amputation level of lower limbs? A compre-hensive review[J]. J Clin Med, 2021, 10: 1413.
[27] Kaspar M, Partovi S, Aschwanden M, et al. Assessment of microcirculation by contrast- enhanced ultrasound: a new approach in vascular medicine[J]. Swiss Med Wkly, 2015, 145: w14047.
[28] Emanuel AL,Meijer RI,van Poelgeest E,et al. Contrastenhanced ultrasound for quantification of tissue perfusion in humans[J]. Microcirculation, 2020, 27: e12588.
[29] Mahmoud A, El- Sharkawy YH. Quantitative phase analysis and hyperspectral imaging for the automatic identification of veins and blood perfusion maps[J]. Photodiagnosis Photodyn Ther, 2023, 42: 103307.
[30] Lopes L, Setia O, Aurshina A, et al. Stem cell therapy for diabetic foot ulcers: a review of preclinical and clinical research[J]. Stem Cell Res Ther, 2018, 9: 188.
[31] Kaushik K, Das A. TWIST1- reprogrammed endothelial cell transplantation potentiates neovascularization- mediated diabetic wound tissue regeneration[J]. Diabetes, 2020, 69: 1232- 1247.
[32] Dai Q, Fan X, Meng X, et al. FGF21 promotes ischaemic angiogenesis and endothelial progenitor cells function under diabetic conditions in an AMPK/NAD+- dependent manner[J]. J Cell Mol Med, 2021, 25: 3091- 3102.
[33] Moon KC, Suh HS, Kim KB, et al. Potential of allogeneic adipose- derived stem cell- hydrogel complex for treating diabetic foot ulcers[J]. Diabetes, 2019, 68: 837- 846.
[34] Hinchliffe RJ, Forsythe RO, Apelqvist J, et al. Guidelines on diagnosis, prognosis, and management of peripheral artery disease in patients with foot ulcers and diabetes(IWGDF 2019 update)[J]. Diabetes Metab Res Rev, 2020, 36: e3276.
[35] Hinchliffe RJ, Brownrigg JR, Apelqvist J, et al. IWGDF guidance on the diagnosis, prognosis and management of peripheral artery disease in patients with foot ulcers in diabetes[J]. Diabetes Metab Res Rev, 2016, 32 Suppl 1: 37- 44.
[36] Asadi MR, Torkaman G, Hedayati M, et al. Angiogenic effects of low- intensity cathodal direct current on ischemic diabetic foot ulcers: a randomized controlled trial[J]. Diabetes Res Clin Pract, 2017, 127: 147- 155.
[37] Chatwin KE, Abbott CA, Reddy PN, et al. A foreign body through the shoe of a person with diabetic peripheral neuropathy alters contralateral biomechanics: captured through innovative plantar pressure technology[J]. Int J Low Extrem Wounds, 2018, 17: 125- 129.
[38] Crisologo PA, Lavery LA. Remote home monitoring to identify and prevent diabetic foot ulceration[J]. Ann Transl Med, 2017, 5: 430.
[39] Yi F, Hou W, Zhou C, et al. Radiofrequency ablation versus antiarrhythmic drug therapy for atrial fibrillation: meta- analysis of safety and efficacy[J]. J Cardiovasc Pharmacol, 2019, 73: 241- 247.
[40] Wang W, Liu D, Li D, et al. Nanofibrous vascular scaffold prepared from miscible polymer blend with heparin/stromal cell- derived factor- 1 alpha for enhancing anticoagulation and endothelialization[J]. Colloids Surf B Biointerfaces, 2019, 181: 963- 972.
[41] Shi Z,Zhang Y,Liu T,et al. Synthesis of BiOBr/Ag3PO4 hetero-junctions on carbon- fiber cloth as filter- membrane- shaped photocatalyst for treating the flowing antibiotic wastewater[J]. J Colloid Interface Sci, 2020, 575: 183- 193.

相似文献/References:

[1]朱悦琦,赵俊功,李明华,等.经足背-足底或足底-足背动脉环逆行腔内成形术治疗糖尿病踝下动脉闭塞性病变的临床研究[J].介入放射学杂志,2011,(03):185.
 ZHU Yue-qi,ZHAO Jun-gong,LI Ming-hua,et al.Retrograde transdorsal-to-plantar or transplantar-to-dorsal intraluminal re-entry treatment following unsuccessful subintimal angioplasty for below-the-ankle arterial occlusion[J].journal interventional radiology,2011,(04):185.
[2]国际血管联盟中国分会糖尿病足专业委员会.糖尿病足诊治指南[J].介入放射学杂志,2013,(09):705.
 Diabetic Foot Committee GU Yong? quan. Guideline on the diagnosis and treatment of diabetic foot China Branch of the International Union of Angiology[J].journal interventional radiology,2013,(04):705.
[3]王春梅,谷涌泉,李建新,等. 糖尿病足介入治疗围手术期处理[J].介入放射学杂志,2013,(09):780.
 WANG Chun? mei,GU Yong? quan,LI Jian? xin,et al. Perioperative management of interventional therapy for diabetic foot[J].journal interventional radiology,2013,(04):780.
[4]李 菁,王 珏. 糖尿病足的影像学研究进展[J].介入放射学杂志,2014,(05):456.
 LI Jing,WANG Jue.. Advances in imaging research of diabetic foot .[J].journal interventional radiology,2014,(04):456.
[5]李 鑫,王黎洲,李 兴,等.糖尿病患者颈动脉支架植入后认知功能与S-100 B蛋白水平探讨[J].介入放射学杂志,2015,(08):653.
 LI Xin,WANG Li- zhou,LI Xing,et al.Investigation of cognitive function and serum S- 100 B protein level in diabetic patients after receiving carotid artery stent implantation[J].journal interventional radiology,2015,(04):653.
[6]马 旭,李跃华,王建波.糖尿病下肢血管病的血管内治疗进展[J].介入放射学杂志,2015,(11):1011.
 MA Xu,LI Yue- hua,WANG Jian- bo.Recent progress in endovascular treatment for diabetic lower extremity vascular disease[J].journal interventional radiology,2015,(04):1011.
[7]田红岸,余开湖,林凤平,等.自体干细胞介入治疗糖尿病足临床效果观察[J].介入放射学杂志,2016,(12):1040.
 TIAN Hong- an,YU Kai- hu,LIN Feng- ping,et al.PTA combined with transplantation of autologous bone marrow stem cells for diabetic foot: observation of clinical effect[J].journal interventional radiology,2016,(04):1040.
[8]刘光华,俞炬明,范国平,等.肝细胞癌患者伴发糖尿病行肝动脉化疗栓塞术的预后因素分析 [J].介入放射学杂志,2017,(10):926.
 LIU Guanghua,YU Juming,FAN Guoping,et al.Analysis of prognostic factors in patients with hepatocellular carcinoma complicated by diabetes mellitus after transcatheter arterial chemoembolization[J].journal interventional radiology,2017,(04):926.
[9]吕在刚,王琳娜,陈晓辉,等.脑血管病伴糖尿病患者介入治疗后对比剂对肾功能的影响 [J].介入放射学杂志,2018,27(03):277.
 LV Zaigang,WANG Linna,CHEN Xiaohui,et al.Effect of contrast media on renal function in patients with cerebrovascular disease complicated by diabetes mellitus after receiving interventional treatment[J].journal interventional radiology,2018,27(04):277.
[10]崔文军,王 兵,安 乾,等.斑块旋切术治疗糖尿病膝下动脉病变效果分析[J].介入放射学杂志,2019,28(05):476.
 CUI Wenjun,WANG Bing,AN Qian,et al.Directional atherectomy for the treatment of infrapopliteal arterial disease in diabetic patients: analysis of its curative effect[J].journal interventional radiology,2019,28(04):476.
[11]中国糖尿病足细胞与介入治疗技术联盟,中国介入医师分会介入医学与生物工程 技术委员会,国家放射与治疗临床医学研究中心.糖尿病足介入综合诊治临床指南(第六版)[J].介入放射学杂志,2020,29(09):853.
 China Alliance of Cellular and Interventional Therapy Techniques for Diabetic Foot,Technical Committee on Interventional Medicine and Bioengineering of Chinese Intervention Physicians Branch,National Centre for Clinical Medical Research on Radiation and Treatment. LI Maoquan..Clinical guidelines for integrated diagnosis and treatment of diabetic foot(sixth edition)[J].journal interventional radiology,2020,29(04):853.

备注/Memo

备注/Memo:
(收稿日期:2023- 09- 15)
(本文编辑:茹 实)
更新日期/Last Update: 2024-05-04